skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Method for preparing radionuclide-labeled chelating agent-ligand complexes

Patent ·
OSTI ID:872538

Radionuclide-labeled chelating agent-ligand complexes that are useful in medical diagnosis or therapy are prepared by reacting a radionuclide, such as .sup.90 Y or .sup.111 In, with a polyfunctional chelating agent to form a radionuclide chelate that is electrically neutral; purifying the chelate by anion exchange chromatography; and reacting the purified chelate with a targeting molecule, such as a monoclonal antibody, to form the complex.

Research Organization:
Univ. of California (United States)
DOE Contract Number:
FG03-84ER60233
Assignee:
Regents of University of California (Oakland, CA)
Patent Number(s):
US 5958374
OSTI ID:
872538
Country of Publication:
United States
Language:
English

References (17)

Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates journal July 1993
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. journal June 1988
Immunochemical aspects of monoclonal antibodies important for radiopharmaceutical development
  • DeNardo, Sally J.; Peng, Jo-Sen B.; DeNardo, Gerald L.
  • International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, Vol. 13, Issue 4 https://doi.org/10.1016/0883-2897(86)90002-4
journal January 1986
A kinetic investigation of the lanthanide DOTA chelates. Stability and rates of formation and of dissociation of a macrocyclic gadolinium(III) polyaza polycarboxylic MRI contrast agent journal March 1992
Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates journal January 1991
The production of 99mTc-labeled conjugated antibodies using a cyclam-based bifunctional chelating agent journal January 1987
Synthesis of C- and N-functionalised derivatives of 1,4,7-triazacyclononane-1,4,7-triyltriacetic acid (NOTA), 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetrayltetra-acetic acid (DOTA), and diethylenenetriaminepenta-acetic acid (DTPA): bifunctional complexing agents for the derivatisation of antibodies journal January 1990
Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions journal October 1984
Thermodynamic and kinetic studies of lanthanide complexes of 1,4,7,10,13-pentaazacyclopentadecane-N,N',N'',N''',N''''-pentaacetic acid and 1,4,7,10,13,16-hexaazacyclooctadecane-N,N',N'',N''',N'''',N'''''-hexaacetic acid journal March 1991
Kinetics of interaction of metal ions with two tetraazatetraacetate macrocycles journal September 1982
Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC [phenyl isothiocyanate]. journal May 1991
The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex journal August 1988
Copper chelates as probes of biological systems: Stable copper complexes with a macrocyclic bifunctional chelating agent journal July 1985
[47] A centrifuged-column procedure for the measurement of ligand binding by beef heart F1 book January 1979
Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies: Radionuclide selection and dose calculations for labeled antibodies journal September 1984
Chimeric L6 anti-tumor antibody. Genomic construction, expression, and characterization of the antigen binding site. journal August 1992
Tumour targeting with radiolabelled macrocycle–antibody conjugates journal January 1990